Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials

Article ID	Journal	Published Year	Pages	File Type
6124627	Osteoarthritis and Cartilage	2015	12 Pages	PDF

Abstract

The present formulation of oral sCT did not provide reproducible clinical benefits in patients with symptomatic knee OAÂ (NCT00486434, NCT00704847).

Keywords

CTX-I ACR JSW WOMAC CTX-II ScT Osteoarthritis Osteocalcin Joint space narrowing Western Ontario and McMaster Universities Osteoarthritis Index body mass index BMI Joint space width Phase III Oral formulation clinical study American College of Rheumatology Salmon calcitonin Calcitonin

Related Topics

Health Sciences Medicine and Dentistry Immunology, Allergology and Rheumatology

Preview

Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials

Authors

M.A. Karsdal, I. Byrjalsen, P. Alexandersen, A. Bihlet, J.R. Andersen, B.J. Riis, A.C. Bay-Jensen, C. Christiansen, the CSMC021C2301/2 investigators the CSMC021C2301/2 investigators,